Lineage Cell Therapeutics Inc

ASE:LCTX  
2.07
-0.10 (-4.61%)
Earnings Announcements

Lineage Posts Quarterly Loss Per Share Of $0.05

Published: 11/10/2021 21:56 GMT
Lineage Cell Therapeutics Inc (LCTX) - Lineage Reports Third Quarter 2021 Financial Results and Highlights Progress From Clinical Cell Therapy Programs.
Qtrly Loss per Share $0.05.
Q3 Earnings per Share View $-0.05 -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $0.64 Million
Adjusted EPS is expected to be -$0.05

Next Quarter Revenue Guidance is expected to be $0.41 Million
Next Quarter EPS Guidance is expected to be -$0.06

More details on our Analysts Page.